Dieterle Christoph D, Schmauss Susanne, Arbogast Helmut, Domsch Christoph, Huber Rudolf M, Landgraf Rüdiger
Department of Internal Medicine, Diabetes Center and Pulmonary Division, Medizinische Klinik Innenstadt, University of Munich, Munich, Germany.
Transplantation. 2007 Mar 15;83(5):566-9. doi: 10.1097/01.tp.0000253882.95177.61.
Pulmonary function is impaired in type 1 diabetes mellitus and is associated with the quality of metabolic control. Correction of chronic hyperglycemia by pancreas transplantation may ameliorate pulmonary function.
Lung volume and diffusing capacity were measured in 75 uremic patients with type 1 diabetes and a long diabetes duration waiting for a simultaneous kidney and pancreas transplantation (SPK). In addition 85 patients after SPK and 20 patients after kidney transplantation alone (KA) were investigated. In a subgroup of 30 patients, data before and after SPK were available for prospective analysis.
Reduced lung volume and diffusing capacity were found in type 1 diabetic patients before transplantation. Nearly all parameters of pulmonary function improved after SPK and KA. A significant change was found for forced expiratory volume at 1 sec (FEV1) and FEV1/forced vital capacity (FVC) (Tiffenau index). A significant amelioration of diffusing capacity was only found in the SPK group but not in the KA group. The prospective investigation revealed significant improvements of pulmonary function after SPK: FEV1 (P=0.001), FVC, (P=0,006), Tiffenau index (P=0.03), and Hb-corrected diffusing capacity (carbon monoxide transfer factor, TCO), P=0.03; transfer coefficient (KCO=TCO corrected for alveolar volume), P=0.01.
Simultaneous pancreas and kidney transplantation is able to attain long-term normoglycemia and to improve pulmonary function in uremic type 1 diabetic patients.
1型糖尿病患者存在肺功能受损,且与代谢控制质量相关。胰腺移植纠正慢性高血糖可能改善肺功能。
对75例等待同期肾胰联合移植(SPK)、患有1型糖尿病且糖尿病病程长的尿毒症患者进行肺容积和弥散功能测定。此外,还对85例接受SPK后的患者和20例仅接受肾移植(KA)后的患者进行了调查。在30例患者的亚组中,可获得SPK前后的数据用于前瞻性分析。
1型糖尿病患者移植前肺容积和弥散功能降低。SPK和KA后几乎所有肺功能参数均有改善。1秒用力呼气容积(FEV1)和FEV1/用力肺活量(FVC)(蒂芬诺指数)有显著变化。仅在SPK组中发现弥散功能有显著改善,而KA组未发现。前瞻性研究显示SPK后肺功能有显著改善:FEV1(P=0.001)、FVC(P=0.006)、蒂芬诺指数(P=0.03)和血红蛋白校正的弥散功能(一氧化碳转运因子,TCO),P=0.03;转移系数(KCO=TCO经肺泡容积校正),P=0.01。
同期肾胰联合移植能够使尿毒症1型糖尿病患者实现长期血糖正常并改善肺功能。